China's Wuhan Institute Files to Patent the Use of Gilead's Remdesivir for Coronavirus
The Wuhan Institute of Virology, part of the China Academy of Sciences, has applied to patent the use of Gilead Sciences' remdesivir to treat the current coronavirus outbreak.The company has partnered with Chinese health authorities to run a Phase III clinical trial to assess remdesivir for trea
